Clinical Trials Directory

Trials / Completed

CompletedNCT07120165

Effectiveness of Myopia Control Interventions : A Comparison of Myopia Control in European Children, Adolescents and Young Adults With Defocus Incorporated Multiple Segments (DIMS) and Highly Aspherical Lenslets (HAL) Spectacles, Atropine, Lenses and Combined Treatments

Status
Completed
Phase
Study type
Observational
Enrollment
114 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
25 Years
Healthy volunteers
Not accepted

Summary

The prevalence of myopia and its complications has risen considerably in recent decades, particularly among children and teenagers. This trend is also spreading in Europe, driven by the increase in screen time and the intensive use of new technologies and social media, particularly among the younger generation. Several treatment options are available today, including pharmacological treatments with atropine eye drops, as well as optical myopia control systems in the form of glasses or contact lenses. These different treatments have been used in clinical practice at Saint-Étienne University Hospital since 2017 for atropine, and more recently with the development of optical myopia control systems and their combinations. Little clinical data has been published to date on these different treatment combinations in the French population. The investigators would therefore like to set up a database to publish their results and share their experience.

Conditions

Interventions

TypeNameDescription
OTHERDemographic data collectionDemographic data collection: age, gender, level of education/study, time spent in near vision, sports practice, medical history
OTHEROphthalmological historyOphthalmological history: age of myopia discovery, parental refraction, previous refractions, presence of a braking treatment
OTHEROphthalmological data at each examinationOphthalmological data at each examination: visual acuity, subjective refraction, cycloplegia with SKIACOL, axial length.
OTHERPotential adverse eventsPotential adverse events: halos, photophobia, stinging, infections, etc.

Timeline

Start date
2024-10-20
Primary completion
2025-05-07
Completion
2025-05-07
First posted
2025-08-13
Last updated
2025-08-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07120165. Inclusion in this directory is not an endorsement.